Surgery
Conditions
Interventions
Case or experimental will be given intrathecal bupivacaine with dexamethasone as adjuvant
Standard Treatment
Sponsors
KCMC Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1 Inclusion criteria ? Patients classified as American Society of Anesthesiologist (ASA) class I-II, ? Planned to undergo lower extremity orthopedic surgery under Spinal Anesthesia ? Patient who consented. ? Patients with age 18 years and above.
Exclusion criteria
Exclusion criteria: Exclusion Criteria ? Patients who are contraindicated to spinal anesthesia. ? Fluid restriction. ? History of using steroid therapy for a long time. ? Chronic pain or daily intake of analgesic.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effectiveness of dexamethasone as an adjuvant to intrathecal bupivacaine versus bupivacaine alone in orthopedic surgery will be determined primarily by the total duration of sensory and motor blockade. The duration of the sensory block was defined from the peak of the sensory block up to when the patient complained of pain at the surgery site. Motor block duration is from the peak of the motor block (Bromage scale score 3) to the complete recovery of motor function (Bromage scale score 0). | — |
Secondary
| Measure | Time frame |
|---|---|
| The supportive outcome measures on investigating the effectiveness of dexamethasone as an adjuvant to intrathecal bupivacaine in orthopedic surgery will be as follows. ? Pain score postoperative using a Numerical Rating Scale (NRS) ? Time for First Postoperative analgesia. | — |
Countries
United Republic of Tanzania
Contacts
Public ContactAlex Lwiza
Medical specialist
Outcome results
None listed